首页> 外国专利> DNA SEQUENCE AND PREPARATION OF ALLERGENE POLENES OF HERBS PH1 P4 USING RECOMBINANT METHODS

DNA SEQUENCE AND PREPARATION OF ALLERGENE POLENES OF HERBS PH1 P4 USING RECOMBINANT METHODS

机译:重组方法制备草药PH1 P4的DNA序列及过敏原

摘要

DNA molecule (I) corresponding to sequences (SEQ ID. No. 1), (SEQ ID. No. 3) and (SEQ ID. No. 5), all of 1503 bp (defined in the specification) are new. Independent claims are also included for the following: (1) DNA (Ia) comprising a sequence of (I) beginning at position 70 and encoding a polypeptide (II) with the properties of the major allergen Phl p4 of Phleum pratense; (2) DNA (Ib) corresponding to a sequence that encodes Phl p4; (3) DNA (Ic) that hybridizes to (I), (Ia) or (Ib) under stringent conditions and is derived from Poaceae; (4) DNA (Id) encoding a polypeptide (IIa) immunologically cross-reactive with Phl p4 and derived from Poaceae; (5) DNA (Ie) containing a fragment, or combination of fragments, of (I)-(Id) and encoding an immunomodulatory, T cell-reactive form of a Group 4 Poaceae allergen; (6) any of (I)-(Ie) encoding an immunomodulatory T cell-reactive fragment that is altered by targeted mutation of an individual codon, elimination or addition; (7) recombinant DNA expression vector, or cloning system, containing any of (I)-(Ie), or the mutants of (6), linked to expression control sequences; (8) host organism transformed with any of the new DNAs or the vector of (7); (9) method for preparing a polypeptide by culturing the hosts of (8); and (10) polypeptides (IIb) encoded by any of (I)-(Ie) or the mutants of (6). ACTIVITY : Antiallergic. No details of tests for antiallergic activity are given. MECHANISM OF ACTION : Vaccine; hyposensitization.
机译:对应于全部1503bp(在说明书中定义)的序列(SEQ ID.No.1),(SEQ ID.No.3)和(SEQ ID.No.5)的DNA分子(I)是新的。还包括以下方面的独立权利要求:(1)包含序列(I)的DNA(Ia),序列(I)从位置70开始,并编码具有鼠李的主要变应原Phl p4的特性的多肽(II); (2)对应于编码Phl p4的序列的DNA(Ib); (3)在严格条件下与(I),(Ia)或(Ib)杂交并衍生自禾本科的DNA(Ic); (4)编码与Phl p4发生免疫交叉反应的多肽(IIa)的DNA(Id),来源于禾本科; (5)DNA(Ie),其包含(I)-(Id)的片段或片段组合,并编码第4族禾本科过敏原的免疫调节性T细胞反应形式; (6)编码免疫调节性T细胞反应性片段的(I)-(Ie)中的任何一个,其通过单个密码子的靶向突变,消除或添加而改变; (7)重组DNA表达载体或克隆系统,其含有与表达控制序列连接的(I)-(Ie)或(6)的突变体。 (8)用任何新的DNA或(7)的载体转化的宿主生物; (9)通过培养(8)的宿主制备多肽的方法; (10)由(I)-(Ie)中任一项或(6)的突变体编码的多肽(IIb)。活动:抗过敏。没有给出抗过敏活性测试的详细信息。作用机理:疫苗;过敏反应。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号